Aortic Dissection
Aortic Dissection
References
- The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease — JAMA (Hagan PG, Nienaber CA, Isselbacher EM, et al.). JAMA 2000;283(7):897-903
- 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines — Circulation, American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines (Isselbacher EM, Preventza O, Black JH 3rd, et al.). Circulation 2022;146(24):e334-e482
- Sensitivity of the aortic dissection detection risk score, a novel guideline-based tool for identification of acute aortic dissection at initial presentation: results from the International Registry of Acute Aortic Dissection — Circulation (Rogers AM, Hermann LK, Booher AM, et al.). Circulation 2011;123(20):2213-2218
- 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases — European Heart Journal, European Society of Cardiology Task Force on the Management of Peripheral Arterial and Aortic Diseases (Mazzolai L, Teixido-Tura G, Lanzi S, et al.). Eur Heart J 2024;45(36):3538-3700
- Canadian Cardiovascular Society Position Statement on the Management of Thoracic Aortic Disease — Canadian Journal of Cardiology, Canadian Cardiovascular Society (Boodhwani M, Andelfinger G, Leipsic J, et al.). Can J Cardiol 2014;30(6):577-589
Clinical Snapshot
Aortic dissection begins with a tear in the intima (inner layer) of the aortic wall, allowing pulsatile arterial blood to enter and separate the layers of the media, creating a blood-filled false lumen alongside the true lumen. The false lumen can propagate along the length of the aorta, compromise branch-vessel blood flow (malperfusion), cause aortic regurgitation by disrupting the aortic valve annulus, or rupture through the adventitia — the outermost layer — causing rapidly fatal hemorrhage.
The Stanford classification is the single most important organizing concept in this chapter, because it directly determines management:[1]
Stanford classification
Type A
Involves the ascending aorta, regardless of where the tear originates or how far the dissection extends distally. A surgical emergency — untreated mortality rises roughly 1-2% per hour in the first 48 hours, and approaches 50% by 48 hours without surgery.
Type B
Confined to the descending aorta, distal to the left subclavian artery, with no ascending aortic involvement. Usually managed medically unless complicated by malperfusion, rupture, refractory pain, or refractory hypertension, in which case it requires urgent intervention.
Regardless of type, the immediate priority the moment dissection is suspected is heart-rate and blood-pressure control to reduce aortic wall shear stress (dP/dt) — started before, and independent of, the diagnostic workup being completed.[2]
Recognize the Condition
Classic presentation
- Sudden, severe, tearing or ripping pain — the hallmark description, often at maximal intensity from the very first moment (unlike the crescendo pattern typical of ACS) — located in the anterior chest for a proximal (Type A) dissection, or the back/interscapular region for a distal (Type B) dissection.
- Migrating pain that moves as the dissection propagates — chest pain moving to the back or abdomen is a genuinely specific clue, though its absence does not exclude dissection.
- Pulse deficit or a blood pressure differential greater than 20 mmHg between the arms (or between an arm and a leg) — reflects a false lumen compromising flow to one side.
- A new diastolic murmur of aortic regurgitation — suggests proximal (Type A) dissection disrupting the aortic valve annulus; may be accompanied by signs of acute heart failure or cardiac tamponade (Beck triad: hypotension, jugular venous distension, muffled heart sounds) if blood dissects into the pericardium.
- Syncope — can reflect tamponade, a cerebral malperfusion event, or a vagal response to severe pain, and is a poor prognostic sign.
- Focal neurologic deficit — from carotid artery involvement, mimicking acute ischemic stroke.
Why this is a critical ACS mimic
The classic triad of tearing pain, pulse/BP differential, and a widened mediastinum on chest x-ray is present together in only a minority of confirmed dissections — up to 10-15% of patients have no pain at all, and up to 30% have a normal chest x-ray. A high index of suspicion is required in any patient presenting with severe chest, back, or abdominal pain who has dissection risk factors, because missing this diagnosis and treating for presumed ACS or pulmonary embolism instead is catastrophic: giving a thrombolytic or a therapeutic-dose anticoagulant to a patient with an undiagnosed dissection converts a surgical emergency into rapid, often fatal hemorrhage or extension of the dissection. Roughly 1-2% of patients who present with dissection also have ECG changes consistent with acute myocardial infarction — most often inferior ST-elevation from dissection involving the right coronary ostium — which is exactly the scenario where a clinician moving straight to a STEMI/fibrinolysis protocol without considering dissection can cause direct harm.[1]
Risk Factors
- Hypertension — present in roughly two-thirds of patients and the single most common risk factor, particularly when poorly controlled.
- Age over 60, and male sex.
- Known thoracic aortic aneurysm or prior aortic dissection.
- Bicuspid aortic valve.
- Atherosclerosis.
- Connective tissue disorders — Marfan syndrome, vascular Ehlers-Danlos syndrome, Loeys-Dietz syndrome — the dominant risk factor in younger patients (typically under 40) without hypertension or atherosclerosis.
- Vasculitis affecting the aorta — giant cell arteritis, Takayasu arteritis.
- Cocaine or other stimulant use — causes an acute, severe hypertensive surge that can precipitate dissection even without underlying aortic disease.
- Prior cardiac or aortic surgery, or a history of aortic instrumentation (e.g., cardiac catheterization).
- Chest trauma (deceleration injury).
- Pregnancy, particularly the third trimester and early postpartum period in a patient with an underlying connective tissue disorder or bicuspid aortic valve — an important and easily missed context (see Special Populations).
- Family history of aortic aneurysm or dissection, even without a confirmed genetic syndrome.
Red Flags & Refer
Suspected aortic dissection is itself the red flag — treat it as a time-critical surgical emergency requiring immediate imaging and simultaneous heart-rate/blood-pressure control; there is no "routine" version of this condition.
- Activate emergency response and urgent surgical consultation immediately for any patient with sudden severe tearing/ripping chest or back pain plus a pulse deficit, a BP differential between limbs, a new diastolic murmur, syncope, or a focal neurologic deficit.
- Before giving any thrombolytic or therapeutic-dose anticoagulant for presumed ACS or pulmonary embolism, actively reconsider dissection if the pain is described as tearing/ripping, migrates, or is maximal at onset; if there is a pulse deficit or limb BP differential; or if the chest x-ray shows a widened mediastinum — these drugs are contraindicated once dissection is suspected or confirmed.
- Hemodynamic instability, hypotension, or signs of cardiac tamponade (Beck triad) — suggests rupture or hemopericardium and requires immediate intervention, not further diagnostic workup first.
- Any new focal neurologic deficit, limb ischemia, oliguria/anuria, or severe abdominal pain in a patient with known or suspected dissection — suggests malperfusion of the brain, a limb, the kidneys, or the mesenteric circulation, and changes a Type B dissection from "manage medically" to "intervene urgently" (see Choose Initial Treatment).
Assessment & Diagnosis
Immediate investigations
- 12-lead ECG — obtained immediately, primarily to evaluate for a concurrent or mimicking acute coronary syndrome. Often normal or shows nonspecific changes in dissection; a normal ECG does not exclude dissection, and conversely, ST-elevation (especially inferior) can be caused by dissection extending into a coronary ostium rather than primary ACS — do not let a positive ECG alone stop you from considering dissection.[1]
- Chest x-ray — a widened mediastinum is the classic finding but is insensitive (absent in up to 30% of confirmed dissections) and must never be relied on to exclude the diagnosis; also assess for a pleural effusion (more common on the left) and loss of the aortic knob contour.
- D-dimer — a very sensitive marker; a value below the standard threshold in a patient with a low pretest probability (see ADD-RS below) makes dissection unlikely and can support a decision not to proceed to CT imaging. D-dimer should not be used in isolation to exclude dissection in a patient with a high-risk presentation, and it is not a substitute for definitive imaging once suspicion is more than low.[3]
- Troponin and other cardiac markers — helpful for identifying concurrent myocardial injury, but do not rule out dissection.
Pretest probability: the Aortic Dissection Detection Risk Score (ADD-RS)
The ADD-RS is a simple 3-category screening tool: 1 point for each of high-risk predisposing conditions (Marfan or other connective tissue disorder, family history of aortic disease, known aortic valve disease, recent aortic manipulation, known thoracic aortic aneurysm), 1 point for high-risk pain features (abrupt onset, severe intensity, tearing/ripping quality), and 1 point for high-risk examination features (pulse deficit or BP differential, focal neurologic deficit with pain, new murmur of aortic regurgitation with pain, hypotension or shock). A score of 0 with a negative D-dimer has a very high negative predictive value and supports pursuing an alternative diagnosis; a score of 1 or more, or any high-risk feature at all, warrants proceeding directly to definitive aortic imaging regardless of D-dimer result.[3]
Definitive imaging
| Modality | Role |
|---|---|
| CT angiography (chest/abdomen/pelvis) | Preferred first-line definitive test in a hemodynamically stable patient — rapid, widely available, and defines the full extent of the dissection, branch-vessel involvement, and malperfusion in one study. |
| Transesophageal echocardiography (TEE) | Preferred when the patient is too hemodynamically unstable to safely leave the resuscitation area for CT — can be performed at the bedside and also assesses aortic regurgitation severity and pericardial effusion. |
| Transthoracic echocardiography (TTE) | Useful as an immediate bedside screen for a proximal dissection, pericardial effusion/tamponade, and aortic regurgitation, but has limited sensitivity for the distal aorta and should not be relied on alone to exclude dissection. |
| MRI/MRA | Excellent sensitivity and specificity without radiation or iodinated contrast, but too slow for the initial emergency evaluation — reserved for a hemodynamically stable patient when CT is contraindicated (e.g., severe contrast allergy) or for surveillance imaging after the acute presentation. |
Treatment Targets
- Reduce aortic wall shear stress (dP/dt) immediately to limit propagation and rupture risk, regardless of eventual type or definitive management.
- Achieve target heart rate under 60 beats per minute and target systolic blood pressure 100-120 mmHg as rapidly as safely possible.
- Control pain adequately — pain itself drives catecholamine release, heart rate, and blood pressure, working against the hemodynamic targets above.
- Route every confirmed Type A dissection to emergency surgery without delay.
- Identify malperfusion, rupture, or refractory symptoms in Type B dissection promptly, since these change management from medical to urgent intervention.
- Establish lifelong blood pressure control and structured imaging surveillance in every survivor, whether managed surgically or medically.
Choose Initial Treatment
Sequencing is mandatory: beta-blocker first, vasodilator only after adequate rate control
1st line an intravenous beta-blocker — esmolol (preferred for its short half-life and easy titration) or labetalol (also provides alpha-blockade and additional vasodilation) — titrated to a target heart rate under 60 bpm and systolic blood pressure 100-120 mmHg (or the lowest pressure that maintains adequate end-organ perfusion — mentation, urine output).[2]
Do not give a vasodilator (nicardipine, nitroprusside, or any other) before adequate beta-blockade is established — a vasodilator given first, or alone, drops blood pressure but triggers reflex sympathetic activation and tachycardia, which raises dP/dt (the rate of pressure rise against the aortic wall) and can actively propagate the dissection. This sequencing point is one of the most important, and most commonly gotten wrong, pharmacotherapy decisions in this condition.[2]
If systolic BP remains above target despite adequate beta-blockade (HR at or near goal), add an IV vasodilator — nicardipine (preferred, easily titrated, no cyanide-toxicity risk) or sodium nitroprusside (effective but requires monitoring for cyanide/thiocyanate toxicity with prolonged or high-dose use, especially in renal impairment).
If a beta-blocker is contraindicated (severe reactive airway disease, high-grade AV block, decompensated heart failure with low output), use a non-dihydropyridine calcium channel blocker (e.g., diltiazem) for rate control instead, still before adding a vasodilator.
Pain control IV opioids (morphine or fentanyl) titrated to effect, given alongside heart-rate/BP control rather than as an afterthought — uncontrolled pain itself sustains catecholamine-driven tachycardia and hypertension that work directly against the hemodynamic targets above.
Type A (ascending aorta involved) emergency surgical repair — obtain cardiothoracic surgery consultation immediately upon suspicion, in parallel with (not after) confirmatory imaging and hemodynamic control; do not delay surgical notification while completing the full diagnostic workup.[2]
Type B, uncomplicated (no malperfusion, rupture, refractory pain, or refractory hypertension) medical management — heart-rate and blood-pressure control as above, continued as the definitive strategy rather than a bridge to surgery, with close monitoring for any sign of complication developing.[2][4]
Type B, complicated (malperfusion of a branch vessel, contained or free rupture, refractory pain, or blood pressure that cannot be controlled despite maximal medical therapy) urgent intervention — thoracic endovascular aortic repair (TEVAR) is preferred over open surgical repair when anatomy is suitable, given lower perioperative morbidity and mortality.[2][4]
Non-Pharmacologic Treatment
- Immediate ICU-level admission with continuous hemodynamic monitoring and an arterial line for beat-to-beat blood pressure measurement — a non-invasive cuff is not adequate for titrating IV antihypertensive infusions in this setting.
- Emergency cardiothoracic surgery consultation the moment Type A dissection is suspected, run in parallel with imaging rather than sequentially after it.
- Thoracic endovascular aortic repair (TEVAR) or open surgical repair for complicated Type B dissection, per Choose Initial Treatment.
- Strict bed rest and a calm, low-stimulation environment during the acute phase to avoid further catecholamine-driven blood pressure surges.
- Avoid any activity that raises intrathoracic or intra-abdominal pressure (straining, Valsalva, vigorous coughing) — provide antiemetics and stool softeners proactively.
- Multidisciplinary genetics referral for a patient with a suspected connective tissue disorder (young age, disproportionate body habitus, joint hypermobility, family history) — informs both the patient's own long-term management and screening of first-degree relatives.
Pharmacologic Treatment Options
| Drug / intervention | Role | Dose / use | Important adverse effects | Teaching points |
|---|---|---|---|---|
| Esmolol Preferred | 1st-line IV beta-blocker for acute rate/BP control | 500 mcg/kg IV loading bolus over 1 min, then 50-200 mcg/kg/min IV infusion, titrated to HR <60 bpm | Hypotension, bradycardia, bronchospasm | Very short half-life (~9 min) makes it easy to titrate or stop quickly if not tolerated. Give before any vasodilator. |
| Labetalol Preferred | 1st-line IV beta-blocker for acute rate/BP control (combined alpha/beta activity) | 20 mg IV over 2 min, then repeat 20-80 mg IV every 10 min (max 300 mg total) or start infusion 0.5-2 mg/min, titrated to HR <60 bpm and SBP 100-120 mmHg | Hypotension, bradycardia, bronchospasm | Provides some vasodilation itself via alpha-blockade, but still give first, before a dedicated vasodilator. |
| Nicardipine Preferred | IV vasodilator added after adequate beta-blockade if SBP remains above target | 5 mg/hr IV infusion, titrate by 2.5 mg/hr every 5-15 min to effect (max 15 mg/hr) | Reflex tachycardia if started without adequate beta-blockade, hypotension, headache, flushing | Do not start before HR is controlled with a beta-blocker — starting a vasodilator first raises dP/dt and can propagate the dissection. |
| Sodium nitroprusside Alternative | IV vasodilator alternative to nicardipine, added after adequate beta-blockade | 0.25-0.5 mcg/kg/min IV infusion, titrate to effect (usual max 2 mcg/kg/min, higher with monitoring) | Reflex tachycardia if started without adequate beta-blockade, cyanide/thiocyanate toxicity with prolonged or high-dose use, hypotension | Same beta-blocker-first sequencing applies. Monitor for toxicity, especially in renal impairment; avoid prolonged high-dose infusions. |
| Diltiazem Alternative | Rate control when a beta-blocker is contraindicated | 0.25 mg/kg IV over 2 min, then 5-15 mg/hr IV infusion, titrated to HR <60 bpm | Hypotension, bradycardia, AV block, worsening heart failure | Reserve for genuine beta-blocker contraindication. Still give before any vasodilator. |
| Morphine Preferred | Pain control, given alongside HR/BP control | 2-4 mg IV every 5-15 min, titrated to effect | Hypotension, respiratory depression, nausea | Uncontrolled pain sustains catecholamine-driven tachycardia and hypertension — treat pain proactively, not as an afterthought. |
| Fentanyl Alternative | Pain control alternative, especially with hemodynamic instability or renal impairment | 25-50 mcg IV every 5-10 min, titrated to effect | Hypotension (less than morphine), respiratory depression | Preferred over morphine when a faster onset/offset or less hypotension is needed. |
Special Populations
Pregnancy
Dissection in pregnancy is rare but disproportionately affects patients with an underlying connective tissue disorder (Marfan syndrome especially) or bicuspid aortic valve, and clusters in the third trimester and early postpartum period — hormonal and hemodynamic changes of pregnancy increase aortic wall stress. Maintain a high index of suspicion in a pregnant or recently postpartum patient with severe chest or back pain, especially with a known connective tissue disorder or aortic root dilation on prior imaging; do not dismiss the presentation as musculoskeletal or reflux-related pain without considering it. Emergency multidisciplinary management (obstetrics, cardiothoracic surgery, maternal-fetal medicine) is required — the same Stanford-type-based approach applies, with delivery timing (often expedited via cesarean, sometimes combined with or immediately followed by aortic repair) individualized to gestational age and maternal stability. Labetalol is the preferred beta-blocker in pregnancy given the extensive safety experience with this agent in obstetric hypertension.
Connective tissue disorders (Marfan syndrome, vascular Ehlers-Danlos syndrome, Loeys-Dietz syndrome)
These patients dissect at smaller aortic diameters and younger ages than the general population, so the same absolute size thresholds used for atherosclerotic aneurysms do not apply — elective repair of an associated aneurysm is considered at a smaller diameter, per the syndrome-specific thresholds in current guidance. After an acute dissection, lifelong beta-blocker therapy is standard, and an angiotensin receptor blocker (losartan) has trial evidence supporting a reduction in aortic root growth rate in Marfan syndrome specifically and is frequently added or substituted for this reason. Refer for genetic counselling and cascade screening of first-degree relatives.[2]
Renal impairment
Adjust contrast strategy for CT angiography where possible without delaying emergency imaging; if sodium nitroprusside is used, monitor closely for cyanide/thiocyanate accumulation, which occurs faster in renal impairment — consider nicardipine preferentially in this setting.
Older adults
Presentation is more likely to be atypical (less classic tearing pain, more often painless or presenting primarily with syncope or altered mentation), and comorbidity burden affects the surgical-risk discussion for Type A repair — but age alone is not a reason to withhold emergency surgical referral, since untreated Type A dissection is uniformly fatal without intervention.
Monitoring & Follow-Up
Continuous arterial-line blood pressure and heart-rate monitoring throughout the acute admission, with the same HR <60 bpm and SBP 100-120 mmHg targets maintained until definitive repair (Type A) or through the full acute medical-management period (uncomplicated Type B). After the acute phase — whether managed surgically or medically — every patient needs lifelong blood pressure control (target generally under 130/80 mmHg, individualized) and continuation of beta-blocker therapy indefinitely, since recurrent dissection and late aneurysm formation both remain elevated risks for life.[2]
Structured imaging surveillance is mandatory for life: CT or MR angiography before discharge to establish a new baseline, then repeated at 1, 3, 6, and 12 months after the acute event or repair, and annually thereafter if stable (more frequently if any change is detected or the aortic diameter is enlarging) — the goal is early detection of aneurysmal degeneration of the residual false lumen, an endoleak after TEVAR, or a new dissection before it becomes symptomatic.[2][4]
Counsel every patient to avoid heavy resistance/isometric exercise and activities involving Valsalva-type straining indefinitely, and to seek immediate emergency care for any recurrence of severe chest, back, or abdominal pain rather than waiting for the next scheduled follow-up.
Treatment Failure / Next Step
- Heart rate or blood pressure remains above target despite an adequately titrated beta-blocker plus a vasodilator: reassess for uncontrolled pain, anxiety, urinary retention, or an underlying secondary cause driving catecholamine release, and treat those directly rather than simply escalating drug doses further; involve critical care for a third agent if genuinely refractory.
- New or worsening malperfusion signs (neurologic deficit, limb ischemia, oliguria, abdominal pain) in a previously uncomplicated Type B dissection: this converts the case to complicated Type B — obtain urgent vascular/cardiothoracic surgery reassessment for TEVAR rather than continuing medical management alone.
- Hemodynamic instability or new signs of tamponade at any point: treat as rupture until proven otherwise and escalate for immediate surgical intervention — do not wait for scheduled repeat imaging.
- Recurrent or progressive dissection identified on surveillance imaging: repeat cross-sectional imaging promptly and refer back to the surgical team that performed the original repair (or vascular/cardiothoracic surgery if managed medically) for reassessment rather than simply extending the surveillance interval.
- New aortic regurgitation murmur or heart failure symptoms developing after initial stabilization: obtain echocardiography promptly — may indicate progression of valve annular disruption requiring surgical reassessment.
Common Errors to Avoid
- Starting a vasodilator (nicardipine, nitroprusside, or any other) before a beta-blocker has achieved adequate rate control — the single most important sequencing error in this condition, since reflex tachycardia from an unopposed vasodilator raises dP/dt and can propagate the dissection.[2]
- Giving a thrombolytic or therapeutic-dose anticoagulant for presumed ACS or pulmonary embolism without first considering dissection, especially when the pain is tearing/migrating, a pulse deficit or limb BP differential is present, or the chest x-ray shows a widened mediastinum.
- Treating an inferior STEMI pattern on ECG as routine ACS without considering that dissection extending into the right coronary ostium can produce the identical ECG picture.
- Relying on a normal chest x-ray, a normal ECG, or the absence of the classic pain/pulse-deficit/murmur triad to exclude dissection — each of these is individually insensitive, and the full classic triad is present together in only a minority of confirmed cases.
- Delaying emergency surgical consultation for a suspected Type A dissection while completing an extensive diagnostic workup — surgical notification should happen in parallel with, not after, confirmatory imaging.
- Treating uncomplicated Type B dissection as a surgical emergency, or conversely, continuing medical management alone once a genuine complication (malperfusion, rupture, refractory pain/hypertension) has developed.
- Stopping surveillance imaging after the first year, or after surgical repair feels "complete" — lifelong imaging surveillance is required regardless of management strategy.
- Missing an underlying connective tissue disorder in a younger patient (under 40) presenting without the usual hypertension/atherosclerosis risk factors — this changes both acute counselling and long-term aortic-size thresholds for family members.
Clinical Decision Algorithm
Drug Tables
How to use this table: Doses are adult doses for acute IV heart-rate/blood-pressure control and require patient-specific confirmation, including renal/hepatic adjustment and institutional protocol. Select any drug name to open its complete Pharmasist Drug Database page.
Beta-blockers (give first, before any vasodilator)
Titrate to heart rate under 60 bpm before adding a vasodilator. Use a non-dihydropyridine calcium channel blocker instead only if a beta-blocker is contraindicated.
| Drug | Dosage | Adverse effects | Drug interactions | Comments |
|---|---|---|---|---|
| Esmolol | Loading dose: 500 mcg/kg IV over 1 minute Infusion: 50-200 mcg/kg/min IV, titrated to HR <60 bpm | Hypotension, bradycardia, bronchospasm | Additive bradycardia/hypotension with other rate- or pressure-lowering agents | Very short half-life (~9 minutes) — easy to titrate rapidly or stop quickly if not tolerated. Preferred first-line agent given this titratability. |
| Labetalol | Bolus: 20 mg IV over 2 min, repeat 20-80 mg IV q10min (max 300 mg total) Infusion alternative: 0.5-2 mg/min IV, titrated to HR <60 bpm and SBP 100-120 mmHg | Hypotension, bradycardia, bronchospasm | Additive bradycardia/hypotension with other rate- or pressure-lowering agents | Combined alpha/beta activity provides some vasodilation itself, but still give before a dedicated vasodilator. Preferred beta-blocker in pregnancy given extensive obstetric safety experience. |
| Diltiazem | Bolus: 0.25 mg/kg IV over 2 min Infusion: 5-15 mg/hr IV, titrated to HR <60 bpm | Hypotension, bradycardia, AV block, worsening heart failure | Additive bradycardia/AV block with beta-blockers or digoxin | Reserve for genuine beta-blocker contraindication (severe reactive airway disease, high-grade AV block, decompensated low-output heart failure). Still give before any vasodilator. |
Vasodilators (add only after adequate beta-blockade)
Never start before heart rate is controlled with a beta-blocker — an unopposed vasodilator causes reflex tachycardia that raises aortic wall shear stress (dP/dt) and can propagate the dissection.
| Drug | Dosage | Adverse effects | Drug interactions | Comments |
|---|---|---|---|---|
| Nicardipine | Infusion: 5 mg/hr IV, titrate by 2.5 mg/hr q5-15min to effect (max 15 mg/hr) | Reflex tachycardia if beta-blockade inadequate, hypotension, headache, flushing | Additive hypotension with other antihypertensives; CYP3A4 interactions | Preferred vasodilator — easily titrated, no cyanide-toxicity risk, favoured over nitroprusside in renal impairment. |
| Sodium nitroprusside | Infusion: 0.25-0.5 mcg/kg/min IV, titrate to effect (usual max 2 mcg/kg/min) | Reflex tachycardia if beta-blockade inadequate, cyanide/thiocyanate toxicity with prolonged or high-dose use, hypotension | Additive hypotension with other antihypertensives | Alternative to nicardipine. Monitor for cyanide/thiocyanate accumulation, especially in renal impairment or with prolonged high-dose infusions; avoid as a first choice when nicardipine is available. |
Analgesia
Treat pain proactively alongside heart-rate/BP control — uncontrolled pain sustains catecholamine-driven tachycardia and hypertension.
| Drug | Dosage | Adverse effects | Drug interactions | Comments |
|---|---|---|---|---|
| Morphine | Dosing: 2-4 mg IV q5-15min, titrated to effect | Hypotension, respiratory depression, nausea | Additive CNS/respiratory depression with other sedatives | First-line analgesic for acute dissection pain. |
| Fentanyl | Dosing: 25-50 mcg IV q5-10min, titrated to effect | Hypotension (less than morphine), respiratory depression | Additive CNS/respiratory depression with other sedatives | Preferred over morphine when a faster onset/offset or less hemodynamic effect is needed, or in renal impairment. |
Long-term therapy after repair or medically managed Type B
Continue indefinitely in every survivor, alongside structured lifelong imaging surveillance.
| Drug | Dosage | Adverse effects | Drug interactions | Comments |
|---|---|---|---|---|
| Metoprolol (or another beta-blocker) | Dosing: Titrated to standard long-term heart-rate and blood-pressure targets | Bradycardia, hypotension, fatigue, bronchospasm | Additive bradycardia with diltiazem/verapamil/digoxin | Continue indefinitely to reduce aortic wall stress and lower recurrence/aneurysm-formation risk, regardless of whether repair was surgical or medical management was chosen. |
| Losartan | Dosing: Titrated to standard long-term blood pressure targets | Hyperkalemia, hypotension, dizziness | Hyperkalemia risk with potassium-sparing diuretics/ACE inhibitors | Add or substitute specifically in Marfan syndrome — trial evidence supports a reduced aortic root growth rate; also a reasonable option for standard long-term blood pressure control in other patients. |
Professional reference only. Apply clinical judgment and verify patient-specific decisions against current authoritative guidance and product information.